BioSpace News Archive

Summit Therapeutics plc announces that management will participate in two panel sessions at the World Antimicrobial Resistance Congress, taking place 7-8 November 2019 in Washington, DC.

Neurana Pharmaceuticals, a biotechnology pharmaceutical company focused on the treatment of neuromuscular conditions, today announced that it has appointed Randall Kaye, M.D., as Chief Medical Officer (CMO)

Granted a US patent covering Tiara™ (“Tiara”) mitral valve replacement device

Sophiris Bio Inc., a biopharmaceutical company studying topsalysin, a first-in-class, pore-forming protein, in late-stage clinical trials for the treatment of patients with urological diseases, reported financial results for the third quarter 2019 and provided an overview of recent corporate highlights.

Aduro Biotech, Inc. provided a business update and reported financial results for the third quarter ended September 30, 2019.

Implemented restructuring to focus resources primarily on the development of cobomarsen and microRNA-29 mimics, including remlarsen

IntelGenx Technologies Corp., a leader in pharmaceutical films, reported financial results for the third quarter ended September 30, 2019. All dollar amounts are expressed in U.S. currency and results are reported in accordance with United States generally accepted accounting principles except where noted otherwise..

Profound Medical Corp. reported financial results for the three and nine months ended September 30, 2019, and provided an update on its operations.

Stephens Nashville Conference on November 13

Phase 2 trial of Sleeping Beauty TCR-T cell therapy for patients with solid tumors initiated at the National Cancer Institute (NCI)